haloperidol has been researched along with salsolinol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antkiewicz-Michaluk, L; Michaluk, J; Papla, I; Romańska, I; Vetulani, J | 1 |
| Fülöp, F; Hashizume, T; Inaba, Y; Nagy, GM; Sawai, K; Watanabe, R | 1 |
2 other study(ies) available for haloperidol and salsolinol
| Article | Year |
|---|---|
Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol.
Topics: Animals; Antiparkinson Agents; Apomorphine; Binding, Competitive; Brain Chemistry; Catalepsy; Dopamine; Dopamine Antagonists; Haloperidol; Homovanillic Acid; Isoquinolines; Male; Motor Activity; Neurotoxins; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Wistar; Tetrahydroisoquinolines; Tritium | 2000 |
Hypothalamic dopamine is required for salsolinol-induced prolactin secretion in goats.
Topics: Animals; Carbidopa; Dopamine; Dopamine D2 Receptor Antagonists; Drug Combinations; Female; Goats; Haloperidol; Hypothalamus; Injections, Intravenous; Isoquinolines; Levodopa; Prolactin; Thyrotropin-Releasing Hormone | 2017 |